{"id":4426,"date":"2019-03-26T06:46:20","date_gmt":"2019-03-26T06:46:20","guid":{"rendered":"https:\/\/www.erdheim-chester.org\/?post_type=study_trials&#038;p=4426"},"modified":"2021-09-27T13:35:47","modified_gmt":"2021-09-27T18:35:47","slug":"histiocytic-neoplasms-biobank-and-database-lymphoma-specialized-programs-of-research-excellence-spore-09-2017-07-2022-and-lymphoma-epidemiology-of-outcomes-leo-cohort-study-leo","status":"publish","type":"study_trials","link":"https:\/\/www.erdheim-chester.org\/hi\/study_trials\/histiocytic-neoplasms-biobank-and-database-lymphoma-specialized-programs-of-research-excellence-spore-09-2017-07-2022-and-lymphoma-epidemiology-of-outcomes-leo-cohort-study-leo\/","title":{"rendered":"Histiocytic neoplasms biobank and database- Lymphoma Specialized Programs of Research Excellence (SPORE) (09\/2017- 07\/2022) and Lymphoma Epidemiology of Outcomes (LEO) Cohort Study (LEO)"},"content":{"rendered":"<p><strong>\u0905\u0927\u094d\u092f\u092f\u0928 \u0915\u093e \u0909\u0926\u094d\u0926\u0947\u0936\u094d\u092f:<\/strong> This is an ongoing biobank and clinical database at Mayo Clinic and the University of Iowa, Rochester that will enroll patients diagnosed with any histiocytic cancer, including Erdheim-Chester disease, and collect and store tissue\/blood samples for current and future studies.&nbsp; Our goal is to study these rare cancers in detail by means of various tests (genetic, inflammatory markers, other lab tests) that can improve our understanding and help identify new treatments.<\/p>\n<p><strong>\u092a\u094d\u0930\u092e\u0941\u0916 \u0905\u0928\u094d\u0935\u0947\u0937\u0915:<\/strong> Thomas E. Witzig, MD, James E. Cerhan, MD, and Ronald S. Go, MD<\/p>\n<p><strong>\u0938\u0902\u092a\u0930\u094d\u0915 \u091c\u093e\u0928\u0915\u093e\u0930\u0940:<\/strong>&nbsp; Ronald S. Go, (507) 284-2511, email: Go.Ronald@mayo.edu<\/p>\n<p><strong>\u0905\u0928\u0941\u0930\u094b\u0927\u093f\u0924 \u0930\u094b\u0917\u0940 \u0938\u0939\u092d\u093e\u0917\u093f\u0924\u093e:<\/strong> Currently enrolling patients with all histiocytic cancers (Erdheim-Chester disease, Langerhans Cell histiocytosis, Rosai-Dorfman disease)<\/p>\n<p><strong>ClinicalTrials.gov \u092a\u0939\u091a\u093e\u0928\u0915\u0930\u094d\u0924\u093e:<\/strong> NCT02736357<\/p>","protected":false},"excerpt":{"rendered":"<p>Study Objective: This is an ongoing biobank and clinical database at Mayo Clinic and the University of Iowa, Rochester that will enroll patients diagnosed with any histiocytic cancer, including Erdheim-Chester [&hellip;]<\/p>\n","protected":false},"featured_media":0,"parent":0,"menu_order":0,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","cybocfi_hide_featured_image":"","wds_primary_study_trials_cat":0,"_links_to":"","_links_to_target":""},"study_trials_cat":[34],"class_list":["post-4426","study_trials","type-study_trials","status-publish","hentry","study_trials_cat-investigative"],"_links":{"self":[{"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/study_trials\/4426","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/study_trials"}],"about":[{"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/types\/study_trials"}],"wp:attachment":[{"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/media?parent=4426"}],"wp:term":[{"taxonomy":"study_trials_cat","embeddable":true,"href":"https:\/\/www.erdheim-chester.org\/hi\/wp-json\/wp\/v2\/study_trials_cat?post=4426"}],"curies":[{"name":"\u0921\u092c\u094d\u0932\u094d\u092f\u0942\u092a\u0940","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}